Digitsole news

A novel study published in the (TBD) issue of Sensors, the leading international,?peer-reviewed, open access journal on the science and technology of sensors – entitled Test-Retest Reliability of PODOSmart® Gait Analysis Insoles – concluded that Digitsole’s PODOSmart®?insoles present excellent repeatability in gait analysis parameters.

Digitsole, a leader in the digital health space bringing together digital mobility biomarkers and biomechanical data with clinical expertise, has received Class II medical device registration with the U.S. Food and Drug Administration (FDA) for its Digitsole Pro® smart insoles.

A study published in the September 2021 issue of Sensors, titled A Novel Tool for Gait Analysis: Validation Study of the Smart Insole PODOSmart® concluded that Digitsole’s PODOSmart® is a valid tool for gait analysis compared to the gold standard Vicon motion system.